zolpidem tartrate NDC 52427-775

NDC codes

FDA NDC Directory

Product NDC (as listed)52427-775Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52427-0775Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52427-775-30	52427077530	30 CAPSULE in 1 BOTTLE (52427-775-30)Marketed from May 24, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): zolpidem tartrate
Generic name (nonproprietary): zolpidem tartrate
Active ingredients: Zolpidem tartrate — 7.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Almatica Pharma LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 215721
Marketing start: May 9, 2023
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Central Nervous System Depression (Physiologic effect)GABA A Receptor Positive Modulators (Mechanism)
Identifiers: Product ID 52427-775_1de7823f-3d49-f5ef-f98b-6d34d2419daeSPL ID 1de7823f-3d49-f5ef-f98b-6d34d2419daeSPL set ID 2f1a3600-9bd6-3651-3ab5-1e4e0b0a3916RxCUI 2637353UNII WY6W63843KUPC 0352427775307
Pharmacologic class: gamma-Aminobutyric Acid A Receptor Positive Modulator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452427077530 followed by a unit qualifier and the quantity

Package 52427-0775-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 9, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Zolpidem Tartrate Capsules are indicated for the short-term treatment of transient insomnia characterized by difficulties with sleep initiation in adults younger than 65 years of age [see Dosage and Administration ( 2.1 ) and Clinical Studies ( 14 )] . Zolpidem Tartrate Capsules, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of transient insomnia characterized by difficulties with sleep initiation in adults younger than 65 years of age ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)